Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from ... Its injectable drugs require both specialized injection pens and cold storage and shipping, so manufacturing and transport are often ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.

Some of the potential iterations of delivery methods Eli ... injector pens to use. “We can think about its use in disease beyond Type 2 diabetes and obesity,” says Dr. Dan Skovronsky, Lilly ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly said its phase 3 trial of GLP-1 drug in pill form found results similar to popular injectables for weight loss. Orforglipron would be used as a daily pill, eliminating the need for ...

Did Eli Lilly just say checkmate to Novo Nordisk? Well, an approval for an oral drug would represent a big victory. First, its likely many people would prefer a daily pill instead of an injection ...